|
1
|
Xu Y, Li W, Liu X, Ma H, Tu Z and Dai Y:
Analysis of microRNA expression profile by small RNA sequencing in
down syndrome fetuses. Int J Mol Med. 32:1115–1125. 2013.PubMed/NCBI
|
|
2
|
Pellegrini FP, Marinoni M, Frangione V,
Tedeschi A, Gandini V, Ciglia F, Mortara L, Accolla RS and Nespoli
L: Down syndrome, autoimmunity and T regulatory cells. Clin Exp
Immunol. 169:238–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jin S, Lee YK, Lim YC, Zheng Z, Lin XM, Ng
DP, Holbrook JD, Law HY, Kwek KY, Yeo GS and Ding C: Global DNA
hypermethylation in down syndrome placenta. PLoS Genet.
9:e10035152013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Costa V, Angelini C, D'Apice L, Mutarelli
M, Casamassimi A, Sommese L, Gallo MA, Aprile M, Esposito R, Leone
L, et al: Massive-scale RNA-Seq analysis of non ribosomal
transcriptome in human trisomy 21. PLoS One. 6:e184932011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang J, Haubrock M, Cao KM, Hua X, Zhang
CY, Wingender E and Li J: Regulatory coordination of clustered
microRNAs based on microRNA-transcription factor regulatory
network. BMC Syst Biol. 5:1992011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
96:(Suppl). R40–R44. 2007.PubMed/NCBI
|
|
7
|
Liao JM, Zhou X, Zhang Y and Lu H:
MiR-1246: A new link of the p53 family with cancer and down
syndrome. Cell Cycle. 11:2624–2630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elton TS, Sansom SE and Martin MM:
Trisomy-21 gene dosage over-expression of miRNAs results in the
haploinsuffciency of specifc target proteins. RNA Biol. 7:540–547.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Malinge S, Izraeli S and Crispino JD:
Insights into the manifestations, outcomes, and mechanisms of
leukemogenesis in down syndrome. Blood. 113:2619–2628. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ozen M, Creighton CJ, Ozdemir M and
Ittmann M: Widespread deregulation of microRNA expression in human
prostate cancer. Oncogene. 27:1788–1793. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elkan-Miller T, Ulitsky I, Hertzano R,
Rudnicki A, Dror AA, Lenz DR, Elkon R, Irmler M, Beckers J, Shamir
R and Avraham KB: Integration of transcriptomics, proteomics, and
MicroRNA analyses reveals novel MicroRNA regulation of targets in
the mammalian inner ear. PLoS One. 6:e181952011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vasilatou D, Papageorgiou S, Pappa V,
Papageorgiou E and Dervenoulas J: The role of microRNAs in normal
and malignant hematopoiesis. Eur J Haematol. 84:1–16. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li R, Yu C, Li Y, Lam TW, Yiu SM,
Kristiansen K and Wang J: SOAP2: An improved ultrafast tool for
short read alignment. Bioinformatics. 25:1966–1967. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (−Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Dai Y, Qi S, Sun B, Wen J, Zhang L
and Tu Z: Comparative proteome analysis of peripheral blood
mononuclear cells in systemic lupus erythematosus with iTRAQ
quantitative proteomics. Rheumatol Int. 32:585–593. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sui W, Lin H, Peng W, Huang Y, Chen J,
Zhang Y and Dai Y: Molecular dysfunctions in acute rejection after
renal transplantation revealed by integrated analysis of
transcription factor, microRNA and long noncoding RNA. Genomics.
102:310–322. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao W, Xu J, Liu L, Shen H, Zeng H and Shu
Y: A systematic-analysis of predicted miR-21 targets identifies a
signature for lung cancer. Biomed Pharmacother. 66:21–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Flynt AS and Lai EC: Biological principles
of microRNA-mediated regulation: Shared themes amid diversity. Nat
Rev Genet. 9:831–842. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Corsini LR, Bronte G, Terrasi M, Amodeo V,
Fanale D, Fiorentino E, Cicero G, Bazan V and Russo A: The role of
microRNAs in cancer: Diagnostic and prognostic biomarkers and
targets of therapies. Expert Opin Ther Targets. 16:(Suppl 2).
S103–S109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Keck-Wherley J, Grover D, Bhattacharyya S,
Xu X, Holman D, Lombardini ED, Verma R, Biswas R and Galdzicki Z:
Abnormal microRNA expression in Ts65Dn hippocampus and whole blood:
Contributions to down syndrome phenotypes. Dev Neurosci.
33:451–467. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Elton TS, Sansom SE and Martin MM:
Trisomy-21 gene dosage overexpression of miRNAs results in the
haploinsufficiency of specific target proteins. RNA Biol.
7:540–547. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao B, Tan L, He B, Liu Z and Xu R:
MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma
cells. J Transl Med. 11:1722013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Rathinam R, Walch A and Alahari
SK: ST14 (suppression of tumorigenicity 14) gene is a target for
miR-27b, and the inhibitory effect of ST14 on cell growth is
independent of miR-27b regulation. J Biol Chem. 284:23094–23106.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim SY, Kim AY, Lee HW, Son YH, Lee GY,
Lee JW, Lee YS and Kim JB: miR-27a is a negative regulator of
adipocyte differentiation via suppressing PPARgamma expression.
Biochem Biophys Res Commun. 392:323–328. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sui W, Zhang R, Chen J, He H, Cui Z, Ou M,
Li W, Qi S, Wen J, Lin X and Dai Y: Quantitative proteomic analysis
of Down syndrome in the umbilical cord blood using iTRAQ. Mol Med
Rep. 11:1391–1399. 2015.PubMed/NCBI
|
|
26
|
Kolla V, Jenö P, Moes S, Tercanli S,
Lapaire O, Choolani M and Hahn S: Quantitative proteomics analysis
of maternal plasma in down syndrome pregnancies using isobaric
tagging reagent (iTRAQ). J Biomed Biotechnol. 2010:9520472010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Langfelder P, Mischel PS and Horvath S:
When is hub gene selection better than standard meta-analysis. PLoS
One. 8:e615052013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shin JH, Guedj F, Delabar JM and Lubec G:
Dysregulation of growth factor receptor-bound protein 2 and fascin
in hippocampus of mice polytransgenic for chromosome 21 structures.
Hippocampus. 17:1180–1192. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gorynia S, Bandeiras TM, Pinho FG, McVey
CE, Vonrhein C, Round A, Svergun DI, Donner P, Matias PM and
Carrondo MA: Structural and functional insights into a dodecameric
molecular machine-the RuvBL1/RuvBL2 complex. J Struct Biol.
176:279–291. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Essawi ML, Ismail MF, Afifi HH, Kobesiy
MM, El Kotoury A and Barakat MM: Mutational analysis of the PTPN11
gene in Egyptian patients with Noonan syndrome. J Formos Med Assoc.
112:707–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peyrl A, Weitzdoerfer R, Gulesserian T,
Fountoulakis M and Lubec G: Aberrant expression of
signaling-related proteins 14-3-3 gamma and RACK1 in fetal down
syndrome brain (trisomy 21). Electrophoresis. 23:152–157. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Slattery ML, Lundgreen A and Wolff RK:
Dietary influence on MAPK-signaling pathways and risk of colon and
rectal cancer. Nutr Cancer. 65:729–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
